Term
Down Syndrome
(Inheritance, Molecular Mechanism) |
|
Definition
Down Syndrome
Inheritance: Chromosomal
Molecular Mechanism: Trisomy 21 |
|
|
Term
Down Syndrome
(Clinical Features) |
|
Definition
Down Syndrome
· Impaired cognition and physical growth
· Facies (characteristic facial feature)
· Ventricular septal defect
· Mental retardation
· Predisposition to hematologic malignancy
· Infertility
· Hypothyroidism
|
|
|
|
Term
Velocardiofacial syndrome (DiGeorges)
(Inheritance, Molecular Mechanism) |
|
Definition
Velocardiofacial syndrome (DiGeorges)
Inheritance: AD
Molecular mechanism:
- Deletion of long arm of chr. 22
- Recurrent Genomic disorder due to many high identical repeats
- Causes migration defects of neural-crest derived tissue (3rd and 4th
- branchial pouches)
|
|
|
Term
Velocardiofacial syndrome (DiGeorges)
(Clinical Features) |
|
Definition
Velocardiofacial syndrome (DiGeorges)
· Birth defects (congenital heart disease, palatal defects, learning disabilities, recurrent infections)
· Cardiac abnormality (tetralogy of fallot)
· Abnormal facies
· Thymic aplasia
· Cleft palate
· Hypocalcemia
Mental retardation
|
|
|
Term
Achondroplasia
(Inheritance, Molecular Mechanism) |
|
Definition
Achondroplasia
Inheritance: AD
Molecular Mechanism:
Gain of function mutation in FGFR3 --> abnormal cartilage formation |
|
|
Term
Achondroplasia
(Clinical Features) |
|
Definition
Achondroplasia
- Dwarfism
- Front bone protrusion
- Lordosis
- Trident hand
|
|
|
Term
Sickle Cell Disease
(Inheritance, Molecular Mechanism) |
|
Definition
Sickle Cell Disease
Inheritance: AR
Molecular Mechanism:
Point mutation in HB-B gene (beta chain of hemoglobin)
Hydrophilic glutamic acid replaced with valine (hydrophobe)
Chr. 11 |
|
|
Term
Sickle Cell Disease
(Clinical Features) |
|
Definition
Sickle Cell Disease
· Splenic and bone crises
· Vaso-occlusive crisis
o Stroke
o Splenic sequestration (can be painful)
§ Hemoglobin and hematocrit levels drop
o Anemia
o Aplastic Crisis (lack of reticulocytes)
o Pain
o Bone Infarcts
o Functional asplenia
|
|
|
|
Term
Neurofibromatosis Type 1
(Inheritance, Molecular Mechanism) |
|
Definition
Neurofibromatosis Type 1
Inheritance: AD
Molecular Mechanism:
· Mutation of neurofibromin gene on chr. 17
· NF negatively regulates Ras (oncogene)
· Loss of NF à increased Ras signaling
|
|
|
|
Term
Neurofibromatosis Type 1
(Clinical Features) |
|
Definition
Neurofibromatosis Type 1
· Variable expressivity
· Freckles
· Café au lait spots
· Bony lesions
· Scoliosis
· Epilepsy
· Learning difficulties
· Glioma
|
|
|
|
Term
Prader-Willi Syndrome
(Inheritance, Molecular Mechanism) |
|
Definition
Prader-Willi Syndrome
Inheritance: Chromosomal
Molecular Mechanism: Genes on paternal chr. 13 are deleted/silenced via imprinting or uniparental disomy |
|
|
Term
Prader-Willi Syndrome
(Clinical Features) |
|
Definition
Prader-Willi Syndrome
· Large, short children with dysmorphic facies
· Hypotonia (low muscle tone)
· Failure to thrive
· Chid-onset hyperphagia
· Mild to moderate mental retardation
· Endocrine dysfunction
o Insulin
o Growth hormone
|
|
|
|
Term
Angelmann Syndrome
(Inheritance, Molecular Mechanism) |
|
Definition
Angelmann Syndrome
Inheritance: Chromosomal
Molecular Mechanism:
· A single gene on maternal chr. 15 is deleted/silenced via imprinting, uniparental disomy, translocation, or mutation
|
|
|
|
Term
Angelmann Syndrome
(Clinical Features) |
|
Definition
Angelmann Syndrome
· Large children, dysmorphic facies and “puppet syndrome”
· Hypotonia
· Failure to thrive
· Child-onset obesity
· Severe mitral-regurge
· Neurologic Dysfunction (“puppet”)
o Hyperflexia
o Tremor
o Ataxia
o Paroxysmal laughter
|
|
|
|
Term
Long QT Syndrome
(Inheritance, Molecular Mechanism) |
|
Definition
Long QT Syndrome
Inheritance: AD/AR
Molecular Mechanism:
· Locus Heterogeneity
· Mutation in several genes leads to prolonged ventricular action potential (increased QT interval)
|
|
|
|
Term
Long QT Syndrome
(Clinical Features) |
|
Definition
Long QT Syndrome
· Cardiac symptoms
o Increased risk of torsade de pointes
o Palpitations
o Fainting
o Sudden death (ventricular fibrillation)
|
|
|
|
Term
Duchenne Muscular Dystrophy
(Inheritance, Molecular Mechanism) |
|
Definition
Duchenne Muscular Dystrophy
Inheritance: XLR, novel mutation
Molecular Mechanism:
· Mutation of dystrophin gene at locus Xp21
· Absence of dystrophin à calcium influx à sarcolema damage à muscle cell/fiber death and replaced by adipose and connective tissue
|
|
|
|
Term
Duchenne Muscular Dystrophy
(Clinical Features) |
|
Definition
Duchenne Muscular Dystrophy
· Rapid muscle degeneration, loss of ambulation (death)
· Progressive neuromuscular disorder (voluntary first)
· Can start in infancy
|
|
|
|
Term
Cystic Fibrosis
(Inheritance, Molecular Mechanism) |
|
Definition
Cystic Fibrosis
Inheritance: AR
Molecular Mechanism: Cl channel dysfunction --> viscious secretions |
|
|
Term
Cystic Fibrosis
(Clinical Features) |
|
Definition
Cystic Fibrosis
· Pulmonary, GI, GU involvement
· Persistent pulmonary infection
· Clumpy, smell stool
· Elevated sweat chloride levels (salty sweat)
· Azoospermia (e.g. lack of vas deferens)
|
|
|
|
Term
Huntington's Disease
(Inheritance, Molecular Mechanism) |
|
Definition
Huntington's Disease
Inheritance: AD
Molecular Mechanism: Trinucleotide disorder due to small tandem repeats of CAG unit (>38 lead to full penetrance)
|
|
|
Term
Huntington's Disease
(Clinical Features) |
|
Definition
Huntington's Disease
· 100% penetrance
· Progressive neural and muscular problems
· Chorea “dance-like movements”
· Dementia
· Seizures
· Atrophy of caudate nucleus
|
|
|
|
Term
Phenylketonuria (PKU)
(Inheritance, Molecular Mechanism) |
|
Definition
Phenylketonuria (PKU)
Inheritance: AR
Molecular Mechanism:
· Phenylalanine Hydroxylase Deficiency
Ph-ase converts phenylalanine to tyrosine, which is important for dopamine and melatonin
|
|
|
Term
Phenylketonuria (PKU) (Clinical Features) |
|
Definition
Phenylketonuria (PKU)
· Build-up of phenylalanine leads to severe mental retardation and other neural conditions
· Behavioural problems
· Hypopigmentation
· Seizures
|
|
|
|
Term
Tetrahydrobiopterin (BH4) deficiency
(Inheritance, Molecular Mechanism) |
|
Definition
Inheritance: AR
Molecular Mechanism:
· Definiciency of BH4, which is cofactor for tyrosine hydroxilase, tryptophan hydroxilase
· Accumulation of Phenylalanine and decrease dopamine, epinephrine, norepinephrine, serotonin, NO
|
|
|
|
Term
Tetrahydrobiopterin (BH4) deficiency
(Clinical Features) |
|
Definition
Similar to PKU, more severe
· Build-up of phenylalanine leads to severe mental retardation and other neural conditions
· Behavioural problems
· Hypopigmentation
· Seizures
|
|
|
|
Term
Propionic Acidemia
(Inheritance, Molecular Mechanism) |
|
Definition
Inheritance: AR
Molecular Mechanism:
· Mutation in both copies of PCCA or PCCB (code for Propionyl CoA Carboxylase)
· There is enzyme deficiency à buildup of propionyl CoA à buildup of propionic acid and buildup of essential amino acids (Val, Met, Iso, Thr)
|
|
|
|
Term
Propionic Acidemia
(Clinical Features) |
|
Definition
· Metabolic acidosis, delayed developed, neurological symptoms
· High Anion gap (accumulation of non-volatile organic acids)
· Normal anion gap (net loss of bicarbonate)
· Hyperammonemia (Propionyl CoA inhibits Urea Cycle)
· Hyperglycenimia (Propionyl CoA inhibits Glycine cleavage)
· Vomiting
· Lethargy à Coma à Death
· Failure to thrive
|
|
|
|
Term
Ornithine Transcarbamylase Deficiency (OTC)
(Inheritance, Molecular Mechanism) |
|
Definition
Inheritance: XLR
Molecular Mechanism:
Deficiency in enzyme that converts ornithine and carbamyl phosphate to citruline à accumulation of ammonia |
|
|
Term
Ornithine Transcarbamylase Deficiency (OTC)
(Clinical Features) |
|
Definition
· Neurlogic symptoms and blood pH abnormal
· Typically presents when babies first eat (72hr)
· Vomiting
· Encephalopathy
· High ammonion
· Respiratory alkalosis
· 70% mortality in males, females usually okay with milder phenotype
|
|
|
|
Term
Galactosemia
(Inheritance, Molecular Mechanism) |
|
Definition
Inheritance: AR
Molecular Mechanism:
GALT deficiency (Galtactose-1-phosphate uridyl transferase), which usually converts galactose-1-P to UDP-galactose à buildup of galactose |
|
|
Term
Galactosemia
(Clinical Features) |
|
Definition
· Hematologic, Ocular, Hepatic, Neuro, and GU presentations
· Newborn coagulopathy
· Liver Dysfunction/filure
· Cataracts
· E.Coli Sepsis
· Primary ovarian failure
· Learning disability
|
|
|
|
Term
Glycogen Storage Disease Type 1a
(inheritance, Molecular Mechanism) |
|
Definition
Inheritance: AR
Molecular Mechanism: Gluocse-6-Phosphtase Defiency (can't break down glycogen to glucose) |
|
|
Term
Glycogen Storage Disease Type 1a
(clinical features) |
|
Definition
· Decreased energy (can’t mobilize glycogen stores), lethargy, liver disease, hypertriglyceridemia
· Severe Hypoglycemia
· Hyperuricemia à Gout (G6P becomes Uric acid)
· Hypertriglyceridemia à Pancreatitis (G6P à Pyruvate à Triglycerides)
· Liver adenomas
· Hepatomegaly
· Renal Disease (uric acid stones)
|
|
|
|
Term
Medium Chain Acyl-CoA Dehydrogenase Deficiency
(Inheritance, Molecular Mechanism) |
|
Definition
Inheritance: AR
Molecular Mechanism: Can't metabolize medium chain fatty acids |
|
|
Term
Medium Chain Acyl-CoA Dehydrogenase Deficiency
(Clinical Features) |
|
Definition
· GI symptoms with associate hyperammonemia leading to neurologic damage
· Fasting Hypoketotic Hypoglycemia
· Responsible for Sudden Infant Death Syndrome
· Liver Disease
o Reye-like symptoms
o Hepatomegaly
o Acute Liver Disease
· Neurologic (lethary, coma, seizures)
|
|
|
|
Term
Gaucher Disease
(Inheritance, Molecular Mechanism)
|
|
Definition
Inheritance: AR
Molecular Mechanism: Most-Common is Lysosomal Storage Disease due to GBA/glucocerebrosidase deficiency, which affects the recycling of glucosylceramide/glucocerebroside |
|
|
Term
Gaucher Disease
(Clinical Features) |
|
Definition
· Glucocerebroside can collect in spleen, liver, kidneys, lung, brain, and bone marrow, so can be pan systemic
o Hepatosplenomegaly
o Bone marrow disease (pancytopenia, thrombocytopenia)
o Skeletal disease (osteopenia, fractures)
§ Bone pain
§ Osteonecrosis/bone infarcts
§ Vertebral compression
§ Erlenmyer flask deformity of femur
· Type I
o Ashkenazi Jews
o Non-neuropathic
o Mostly visceral and skeletal disease
· Type II
o Neurodegenerative, fatal by 2 years of age
· Type III
o Intermediate
o More common in Swedes
|
|
|
|
Term
MELAS
(Inheritance, Molecular Mechanism) |
|
Definition
Inheritance: Mitochondrial
Molecular Mechanism:
· Heteroplasmy due to ratio of good/bad mitochondria across cells, tissues, etc.
· Variable inheritance and severity of disease
· Threshold effect – need to cross certain ratio of good/bad mitochondria to see symptoms/signs
· Due to mutation in mitochondrial gene for NADH dehydrogenase and nuclear gene MT-TL1
· Similar disorders can occur due to any other problems in mitochondrial or nuclear genes responsible for function electron transport chain
|
|
|
|
Term
MELAS
(Clinical Features) |
|
Definition
· Multi-system disorder (most common are muscle and neurologic problems accompanied by Lactic Acidosis (build up of Lactic Acid since there’s no Krebs cycle or ETC)
· Lactic Acidosis
· Myopathy (exercise intolerance)
· Cardiomyopathy
· Hepatopathy
· Developmental Delay
· Deafness
· Blindness
· Stroke-like episodes
· Diabetes Mellitus/Insipidus
· Short stature
· Tonic clonic seizure (hemiparesis, cortical blindness)
· Headaches
· Anorexia
· Vomiting
· Altered consciousness
|
|
|
|
Term
Marfan Syndrome
(Inheritance, molecular Mechanism) |
|
Definition
Inheritance: AD
Molecular Mechanism:
· FBN1 mutation (gene responsible for fibrillin-1) - majority
· TGFBR mutation – minority
· The above is example of locus heterogeneity – mutations on different genes give you same disease
· Fibrillin-1 is important in elastic and non-elastic connective tissue (elastin containing matrix, aorta, tenoligament, and ciliary zonules of the eye)
· TGFBR – increased bioavailability of TGF-beta
|
|
|
|
Term
Marfan Syndrome
(Clinical Features) |
|
Definition
· Clinical signs involve skeletal, cardiovascular, and ocular systems (tissues with abundant type 1 collagen)
· Ocular
o Myopia (lens displacement from center of pupil)
o Increased risk for glaucoma, retinal detachment, cataracts
· Cardiovascular
o Dilatation of aorta
o Aortic tear, rupture, dissection
o Mitral prolapsed
o Tricuspid valve prolapse
· Skeletal
o Bone overgrowth
o Joint Laxity
o Long Limbs (dolichostenomelia)
o Rib overgrowth can lead to deviated sternum
§ Pectus excavatum (pushed in)
§ Pectus carinatum (pushed out)
o Scoliosis
|
|
|
|